Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Hepatic Resection for Liver Cancer With PVTT, HVTT or IVCTT After Initial Ate/Bev [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating hepatic resection for hepatocellular carcinoma with PVTT, HVTT, or IVCTT after initial atezolizumab/bevacizumab therapy, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Tecentriq (atezolizumab)

Snippet

Sponsor: Jia Fan | Conditions: Venous Thrombosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING